Urinary excretion of free cysteine in critically ill neonates.
In preliminary observations, significant amounts of free cysteine, a neurotoxic amino acid, were noted in the urine of asphyxiated or septic-shocked neonates. The present study was conducted to determine whether free urinary cysteine was elevated in these critically ill neonates compared with a control group, and to assess the clinical significance of this generation. Free cysteine was measured in the urine of newborn infants with perinatal asphyxia (n = 16) or neonatal sepsis (n = 14) and the urine of a control group (n = 10) by ion-exchange chromatography. Relationships between cysteine levels and the clinical severity, sulfite supply and neurological outcome of the patients were then studied. Urinary cysteine was 27.6 (15-49) mmol mol(-1) creatinine for the patients but was not detectable in the control group. Cysteine levels were correlated with the severity of neonatal septic shock but not with the grade of perinatal asphyxia and did not have a specific influence on the neurological outcome of these patients. The correlation between cysteine level and the severity of neonatal septic shock was indirect and probably linked to higher sulfite administration in this population.


CONCLUSIONS
The mean daily supply of sulfites is high in critically ill neonates, mainly originating from dopamine and generating significant amounts of cysteine. Although a worsening effect attributable to cysteine on the neurological outcome of the patients could not be demonstrated, the appropriateness of cryptic administration of sulfites by way of drug excipients is called into question.
Cambonie
G
G
Neonatal and Paediatric Intensive Care Unit, Hĵpital Arnaud de Villeneuve, Montpellier, France. g-cambonie@chu-montpellier.fr
Bellet
H
H
Houdon
L
L
Vallat
C
C
El Younsi
M
M
Vergnes
C
C
D001034:Apgar Score; D001238:Asphyxia Neonatorum / Q000150:complications* / Q000188:drug therapy / Q000652:urine*; D016638:Critical Illness; D003545:Cysteine / Q000652:urine*; D005865:Gestational Age; D006801:Humans; D007231:Infant, Newborn; D009422:Nervous System Diseases / Q000209:etiology* / Q000652:urine; D017063:Outcome Assessment, Health Care; D012720:Severity of Illness Index; D012772:Shock, Septic / Q000150:complications* / Q000188:drug therapy / Q000652:urine*; D013447:Sulfites / Q000009:adverse effects / Q000627:therapeutic use
D013447:Sulfites; D003545:Cysteine